UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000059898
Receipt number R000068501
Scientific Title Safety and Efficacy of a Remote Rehabilitation Program for Older Adults with Frailty or Prefrailty: A Randomized Controlled Trial
Date of disclosure of the study information 2025/11/27
Last modified on 2025/11/27 13:31:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the Safety and Efficacy of a Remote Rehabilitation Program for Older Adults with Frailty or Prefrailty

Acronym

Tele-Reha Study

Scientific Title

Safety and Efficacy of a Remote Rehabilitation Program for Older Adults with Frailty or Prefrailty: A Randomized Controlled Trial

Scientific Title:Acronym

Tele-Reha RCT

Region

Japan


Condition

Condition

Frailty or Pre frailty

Classification by specialty

Geriatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to compare a remote rehabilitation program with self-directed training consisting of exercise instruction alone in older adults with frailty or prefrailty, and to evaluate the safety and efficacy of the remote rehabilitation program through a randomized controlled trial.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Primary endpoint
Safety:
Adverse events occurring during remote rehabilitation
Hospital readmission
Incidence of falls

Efficacy:
Rate of change in handgrip strength
Rate of change in the Short Physical Performance Battery (SPPB) score

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Intervention group:
Participants receive remote rehabilitation once per week using a tablet device and video communication (FaceTime or Skype). Vital signs are measured prior to exercise to confirm safety. Patients also perform home-based exercises using provided instructional videos.

Common procedures:
Both groups undergo activity monitoring using a wearable device (Fitbit).
Randomization is conducted using a stratified permuted block method with BMI as the stratification factor, implemented through an Interactive Web Response System (IWRS; RedCAP).

Interventions/Control_2

Control group:
Participants perform self-directed training based only on exercise instruction. Exercise adherence is reviewed during routine outpatient visits, and additional instruction is provided as needed.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Regularly attending outpatient clinics in the relevant departments
2.Over 65 years old
3.Able to walk independently (including with a cane)
4.Provided written informed consent
5.Living with a cohabiting family member

Key exclusion criteria

1.Unable to walk independently or unable to complete interviews/questionnaires
2.Severe cerebrovascular, cardiac, respiratory, hepatic, renal, gastrointestinal, or endocrine/metabolic disease
3.Estimated life expectancy is less than one year due to malignancy or other conditions
4.Severe physical disability requiring long-term rehabilitation
5.Deemed ineligible for participation by the attending physician

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Katsumi
Middle name
Last name Miyauchi

Organization

Juntendo University School of Medicine Affiliated Juntendo Tokyo Koto Geriatric Medical Center

Division name

Department of Cardiology

Zip code

136-0075

Address

Shinsuna 3-3-20, Koto-ku, Tokyo, Japan

TEL

03-5632-3111

Email

ktmmy@juntendo.ac.jp


Public contact

Name of contact person

1st name Kei
Middle name
Last name Matsuno

Organization

Juntendo University School of Medicine Affiliated Juntendo Tokyo Koto Geriatric Medical Center

Division name

Department of Respiratory medicine

Zip code

1350075

Address

Shinsuna 3-3-20, Koto-ku, Tokyo, Japan

TEL

0356323111

Homepage URL


Email

kmatsuno@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee, Faculty of Medicine, Juntendo University

Address

Hongo 3-1-3, Bunkyo-ku, Tokyo, Japan

Tel

0358021584

Email

hongo-rinri@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 11 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 12 Month 25 Day

Date of IRB

2024 Year 04 Month 25 Day

Anticipated trial start date

2024 Year 09 Month 01 Day

Last follow-up date

2025 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 11 Month 27 Day

Last modified on

2025 Year 11 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068501